name,category,termsATP/GTP binding protein-like 2,INTERPRO[450000726$IPR000834:Peptidase M14, carboxypeptidase A]
ATP/GTP binding protein-like 2,SMART[760000546$SM00631:Zn_pept]
ATP/GTP binding protein-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
ATP/GTP binding protein-like 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014082$chain:Cytosolic carboxypeptidase 2, 850106218$metal ion-binding site:Zinc, 850117295$sequence variant, 850118574$splice variant]
CASP8 and FADD-like apoptosis regulator,BBID[10000060$36.Death_of_Key_Intracellular_Targets, 10000108$86.Apoptosis_Nematode&_Vert]
CASP8 and FADD-like apoptosis regulator,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation]
CASP8 and FADD-like apoptosis regulator,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core]
CASP8 and FADD-like apoptosis regulator,KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
CASP8 and FADD-like apoptosis regulator,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030829$PIRSF500657:Casp8 and Fadd-like apoptosis regulator]
CASP8 and FADD-like apoptosis regulator,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
CASP8 and FADD-like apoptosis regulator,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000733$host-virus interaction, 790001212$polymorphism, 790001304$repeat]
CASP8 and FADD-like apoptosis regulator,UP_SEQ_FEATURE[850009799$chain:CASP8 and FADD-like apoptosis regulator subunit p12, 850009800$chain:CASP8 and FADD-like apoptosis regulator subunit p43, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106259$mutagenesis site, 850111188$region of interest:Caspase, 850112147$region of interest:Interaction with caspase-3, 850112149$region of interest:Interaction with caspase-8, 850112150$region of interest:Interaction with caspase-8 propeptide, 850112151$region of interest:Interaction with caspase-8 subunits p18 and p10, 850112316$region of interest:Interaction with FADD, 850112968$region of interest:Interaction with TRAF1 and TRAF2, 850113791$region of interest:Not proteolytically processed and involved in apoptosis inhibition, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
SEC14-like 2 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 2 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 2 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000876$lipid-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001558$transport]
SEC14-like 2 (S. cerevisiae),UP_SEQ_FEATURE[850059082$chain:SEC14-like protein 2, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,COG_ONTOLOGY[90000007$Amino acid transport and metabolism]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,INTERPRO[450013233$IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,UP_SEQ_FEATURE[850065454$chain:Transcription initiation factor TFIID subunit 2, 850102540$compositionally biased region:His-rich, 850102554$compositionally biased region:Lys-rich, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
TBC1 domain family, member 4,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
TBC1 domain family, member 4,SMART[760000143$SM00164:TBC, 760000407$SM00462:PTB]
TBC1 domain family, member 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
TBC1 domain family, member 4,UP_SEQ_FEATURE[850063677$chain:TBC1 domain family member 4, 850102597$compositionally biased region:Ser-rich, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TH1-like (Drosophila),INTERPRO[450006340$IPR006942:TH1 protein]
TH1-like (Drosophila),SP_PIR_KEYWORDS[790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
TH1-like (Drosophila),UP_SEQ_FEATURE[850033823$chain:Negative elongation factor C/D, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
UEV and lactate/malate dehyrogenase domains,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450001087$IPR001236:Lactate/malate dehydrogenase, 450001383$IPR001557:L-lactate/malate dehydrogenase, 450008125$IPR008883:Tumour susceptibility gene 101, 450014366$IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal, 450014426$IPR016040:NAD(P)-binding domain, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
UEV and lactate/malate dehyrogenase domains,PIR_SUPERFAMILY[630000119$PIRSF000102:Lac_mal_DH]
UEV and lactate/malate dehyrogenase domains,SMART[760000185$SM00212:UBCc]
UEV and lactate/malate dehyrogenase domains,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001006$nad, 790001593$ubl conjugation pathway]
UEV and lactate/malate dehyrogenase domains,UP_SEQ_FEATURE[850068113$chain:Ubiquitin-conjugating enzyme E2 variant 3, 850105607$domain:UEV, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
activin A receptor, type IIB,INTERPRO[450000286$IPR000333:Activin type II receptor, 450000401$IPR000472:TGF-beta receptor/activin receptor, type I/II, 450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014202$IPR015768:Activin type II receptor, C-terminal, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
activin A receptor, type IIB,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038850$hsa04350:TGF-beta signaling pathway]
activin A receptor, type IIB,OMIM_DISEASE[520002317$Heterotaxy, visceral, 4, autosomal, 520002803$Left-right axis malformations]
activin A receptor, type IIB,PIR_SUPERFAMILY[630000737$PIRSF000627:type II serine/threonine-protein kinase receptor, Activin/BMP types, 630030675$PIRSF500456:Activin receptor, type IIB]
activin A receptor, type IIB,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000685$heterotaxy, 790000825$kinase, 790000899$magnesium, 790000906$manganese, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism, 790001301$receptor, 790001388$serine/threonine-protein kinase, 790001405$signal, 790001547$transferase, 790001555$transmembrane]
activin A receptor, type IIB,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850003684$chain:Activin receptor type-2B, 850102883$disulfide bond, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
adenylate kinase 3,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 3,KEGG_PATHWAY[470038744$hsa00240:Pyrimidine metabolism]
adenylate kinase 3,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000639$gtp-binding, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001547$transferase]
adenylate kinase 3,UP_SEQ_FEATURE[850000229$binding site:AMP, 850022628$chain:GTP:AMP phosphotransferase mitochondrial, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
aldehyde dehydrogenase 8 family, member A1,INTERPRO[450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal]
aldehyde dehydrogenase 8 family, member A1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001006$nad, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
aldehyde dehydrogenase 8 family, member A1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000114$active site:Proton acceptor, 850004339$chain:Aldehyde dehydrogenase family 8 member A1, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant, 850118573$site:Transition state stabilizer, 850118574$splice variant]
atlastin GTPase 1,INTERPRO[450014315$IPR015894:Guanylate-binding protein, N-terminal]
atlastin GTPase 1,OMIM_DISEASE[520004565$Spastic paraplegia-3A]
atlastin GTPase 1,SP_PIR_KEYWORDS[790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000639$gtp-binding, 790000675$hereditary spastic paraplegia, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
atlastin GTPase 1,UP_SEQ_FEATURE[850006413$chain:Atlastin-1, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850114800$region of interest:Sufficient for membrane association, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,INTERPRO[450000753$IPR000863:Sulfotransferase, 450014790$IPR016469:Carbohydrate sulfotransferase]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,PIR_SUPERFAMILY[630005810$PIRSF005883:carbohydrate sulfotransferase, 630005811$PIRSF005883:Carbohydrate_sulfotransferase]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000615$glycolysis, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001460$sulfate transport, 790001464$sulfotransferase, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,UP_SEQ_FEATURE[850009416$chain:Carbohydrate sulfotransferase 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chemokine (C-X-C motif) receptor 5,BBID[10000043$16.Chemokines-rec-T-cells]
chemokine (C-X-C motif) receptor 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000922$IPR001053:C-X-C chemokine receptor, type 5, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
chemokine (C-X-C motif) receptor 5,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-X-C motif) receptor 5,PIR_SUPERFAMILY[630030051$PIRSF038545:chemokine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
chemokine (C-X-C motif) receptor 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000153$b-cell activation, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
chemokine (C-X-C motif) receptor 5,UP_SEQ_FEATURE[850008769$chain:C-X-C chemokine receptor type 5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 1 open reading frame 216,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 1 open reading frame 216,UP_SEQ_FEATURE[850097494$chain:UPF0500 protein C1orf216, 850117294$sequence conflict]
chromosome 21 open reading frame 62,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 21 open reading frame 62,UP_SEQ_FEATURE[850073774$chain:Uncharacterized protein C21orf62, 850117294$sequence conflict]
chromosome 9 open reading frame 98,INTERPRO[450000742$IPR000850:Adenylate kinase]
chromosome 9 open reading frame 98,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001547$transferase]
chromosome 9 open reading frame 98,UP_SEQ_FEATURE[850049318$chain:Putative adenylate kinase-like protein C9orf98, 850106263$nucleotide phosphate-binding region:ATP, 850110876$region of interest:Adenylate kinase, 850117295$sequence variant, 850118574$splice variant]
endothelin converting enzyme 1,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
endothelin converting enzyme 1,INTERPRO[450000617$IPR000718:Peptidase M13, neprilysin, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008005$IPR008753:Peptidase M13, 450016770$IPR018497:Peptidase M13, neprilysin, C-terminal]
endothelin converting enzyme 1,OMIM_DISEASE[520002339$Hirschsprung disease, cardiac defects, and autonomic dysfunction, 520002479$Hypertension, essential, susceptibility to]
endothelin converting enzyme 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000693$hirschsprung disease, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
endothelin converting enzyme 1,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850017442$chain:Endothelin-converting enzyme 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
gamma-aminobutyric acid (GABA) receptor, rho 2,INTERPRO[450005468$IPR006028:Gamma-aminobutyric acid A receptor, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450007394$IPR008057:Gamma-aminobutyric-acid A receptor, Rho, 450007396$IPR008059:Gamma-aminobutyric-acid A receptor, Rho2, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
gamma-aminobutyric acid (GABA) receptor, rho 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
gamma-aminobutyric acid (GABA) receptor, rho 2,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
gamma-aminobutyric acid (GABA) receptor, rho 2,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001223$postsynaptic cell membrane, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
gamma-aminobutyric acid (GABA) receptor, rho 2,UP_SEQ_FEATURE[850020499$chain:Gamma-aminobutyric acid receptor subunit rho-2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glial fibrillary acidic protein,BIOCARTA[30000239$h_prionPathway:Prion Pathway]
glial fibrillary acidic protein,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450006225$IPR006821:Intermediate filament, DNA-binding region, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
glial fibrillary acidic protein,OMIM_DISEASE[520000214$Alexander disease]
glial fibrillary acidic protein,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
glial fibrillary acidic protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790001162$phosphoprotein, 790001212$polymorphism]
glial fibrillary acidic protein,UP_SEQ_FEATURE[850021232$chain:Glial fibrillary acidic protein, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111277$region of interest:Coil 2A, 850111278$region of interest:Coil 2B, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hippocampus abundant transcript 1,INTERPRO[450001735$IPR001958:Tetracycline resistance protein, TetA, 450005276$IPR005829:Sugar transporter, conserved site, 450010529$IPR011701:Major facilitator superfamily MFS-1]
hippocampus abundant transcript 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
hippocampus abundant transcript 1,UP_SEQ_FEATURE[850023767$chain:Hippocampus abundant transcript 1 protein, 850102577$compositionally biased region:Poly-Lys, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
keratin associated protein 10-7,INTERPRO[450002214$IPR002494:Keratin, high sulphur B2 protein]
keratin associated protein 10-7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000821$keratin, 790001212$polymorphism, 790001304$repeat]
keratin associated protein 10-7,UP_SEQ_FEATURE[850027243$chain:Keratin-associated protein 10-7, 850110309$region of interest:30 X 5 AA repeats of C-C-X(3), 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115444$repeat:30, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
mitochondrial ribosomal protein L36,INTERPRO[450000402$IPR000473:Ribosomal protein L36]
mitochondrial ribosomal protein L36,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein L36,UP_SEQ_FEATURE[850001779$chain:39S ribosomal protein L36, mitochondrial, 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion]
myosin IE,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001294$IPR001452:Src homology-3 domain, 450001427$IPR001609:Myosin head, motor region, 450009949$IPR010926:Myosin tail 2]
myosin IE,SMART[760000009$SM00015:IQ, 760000214$SM00242:MYSc, 760000295$SM00326:SH3]
myosin IE,SP_PIR_KEYWORDS[790000019$actin-binding, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000986$motor protein, 790001002$myosin, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001398$sh3 domain]
myosin IE,UP_SEQ_FEATURE[850033061$chain:Myosin-Ie, 850104439$domain:IQ, 850104809$domain:Myosin head-like, 850105350$domain:SH3, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110834$region of interest:Actin-binding, 850117294$sequence conflict]
nucleophosmin/nucleoplasmin, 2,INTERPRO[450003812$IPR004301:Nucleoplasmin]
nucleophosmin/nucleoplasmin, 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus]
nucleophosmin/nucleoplasmin, 2,UP_SEQ_FEATURE[850035209$chain:Nucleoplasmin-2, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys]
vacuolar protein sorting 33 homolog A (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
vacuolar protein sorting 33 homolog A (S. cerevisiae),INTERPRO[450001435$IPR001619:Sec1-like protein]
vacuolar protein sorting 33 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630029847$PIRSF038240:vacuolar protein sorting-associated protein 33]
vacuolar protein sorting 33 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000501$endosome, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
vacuolar protein sorting 33 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850099933$chain:Vacuolar protein sorting-associated protein 33A, 850117295$sequence variant]
